Alps Group Inc (ALPS) Research

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

Market snapshot

Symbol
ALPS
Price
$0.72
Day change
+3.15%
Market cap
$119.8M
P/E ratio
-0.04x
52-week range
0.562-2.9
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Avanti Helium Corp. (ARGYF)
  • Brenmiller Energy Ltd (BNRG)
  • Chesapeake Granite Wash Trust (CHKR)
  • Edible Garden AG Incorporated (EDBL)
  • Generation Income Properties, Inc. (GIPR)
  • Granite Ridge Resources, Inc (GRNT)
  • Hugoton Royalty Trust (HGTXU)
  • Indonesia Energy Corporation Limited (INDO)

Recent insider activity

  • Lee Hee Hang — trade (0 shares) on 2026-04-17
  • Poh Chit Laa — trade (0 shares) on 2026-03-18
  • Chua Boon Ping — trade (0 shares) on 2026-03-18
  • Chew Yoke Ling — trade (0 shares) on 2026-03-18
  • Cheing Lye-Ping — trade (0 shares) on 2026-03-18

Open Alps Group Inc (ALPS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.